Skip to main content
Top
Published in:

07-12-2024 | Obesity | ASO Author Reflections

ASO Author Reflections: Patients with Obesity may Benefit Uniquely from a Retroperitoneal Approach in Pheochromocytoma Resection

Authors: Kevin Verhoeff, MD, PhD, Alessandro Parente, MD, PhD, Robert P. Sutcliffe, MA, MD

Published in: Annals of Surgical Oncology | Issue 3/2025

Login to get access

Excerpt

Adrenalectomy is the sole curative therapy and the current gold standard of care for patients with pheochromocytoma. Historically, nearly 50% of patients with pheochromocytoma were obese but with increasing rates of obesity these rates continue to increase substantially. Studies evaluating the safety of adrenalectomy for pheochromocytoma remain limited with the largest of eight previous studies including only 177 patients and all other studies having < 100 patients with obesity1. Furthermore, studies evaluating a retroperitoneal approach in patients with obesity were limited to 41 and 141 obese patients, respectively2,3. Considering this, understanding the impact of obesity on outcomes following adrenalectomy for pheochromocytoma is needed and becoming increasingly important from a patient selection and counseling perspective and from a quality improvement viewpoint. …
Literature
1.
go back to reference Xia Z, Liu H, Gu P, et al. Peri- and postoperative outcomes of laparoscopic adrenalectomy in nonobese versus obese patients: a systematic review and meta-analysis. Wideochir Inne Tech Maloinwazyjne. 2022;17(3):430–40.PubMedPubMedCentral Xia Z, Liu H, Gu P, et al. Peri- and postoperative outcomes of laparoscopic adrenalectomy in nonobese versus obese patients: a systematic review and meta-analysis. Wideochir Inne Tech Maloinwazyjne. 2022;17(3):430–40.PubMedPubMedCentral
2.
go back to reference Hu Q, Hang Z, Ho Y, et al. Impact of obesity on perioperative outcomes of retroperitoneal laparoscopic adrenalectomy. Urol Int. 2015;95(3):361–6.CrossRefPubMed Hu Q, Hang Z, Ho Y, et al. Impact of obesity on perioperative outcomes of retroperitoneal laparoscopic adrenalectomy. Urol Int. 2015;95(3):361–6.CrossRefPubMed
3.
go back to reference Zonča P, Bužga M, Ihnát P, Martínek L. Retroperitoneoscopic adrenalectomy in obese patients: is it suitable? Obes Surg. 2015;25(7):1203–8.CrossRefPubMed Zonča P, Bužga M, Ihnát P, Martínek L. Retroperitoneoscopic adrenalectomy in obese patients: is it suitable? Obes Surg. 2015;25(7):1203–8.CrossRefPubMed
5.
go back to reference Parente A, Verhoeff K, Wang Y, et al. International pheo study group. Robotic and laparoscopic adrenalectomy for pheochromocytoma: an international multicenter study. Eur Urol Focus. 2024;S2405-4569(24)00168-8. Parente A, Verhoeff K, Wang Y, et al. International pheo study group. Robotic and laparoscopic adrenalectomy for pheochromocytoma: an international multicenter study. Eur Urol Focus. 2024;S2405-4569(24)00168-8.
Metadata
Title
ASO Author Reflections: Patients with Obesity may Benefit Uniquely from a Retroperitoneal Approach in Pheochromocytoma Resection
Authors
Kevin Verhoeff, MD, PhD
Alessandro Parente, MD, PhD
Robert P. Sutcliffe, MA, MD
Publication date
07-12-2024
Publisher
Springer International Publishing
Published in
Annals of Surgical Oncology / Issue 3/2025
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-024-16669-9
SPONSORED

Mastering chronic pancreatitis pain: A multidisciplinary approach and practical solutions

Severe pain is the most common symptom of chronic pancreatitis. In this webinar, experts share the latest insights in pain management for chronic pancreatitis patients. Experts from a range of disciplines discuss pertinent cases and provide practical suggestions for use within clinical practice.

Sponsored by:
  • Viatris
Developed by: Springer Healthcare
Watch now
Video